👨🏻⚕️ Med-Derm Resident PGY-5 @BrighamMedRes @HMSCombinedDerm 🎓 @harvardmed, @Cal 🎷 @saxyderms 🏳️🌈 (he/him)
Boston, MA
Joined April 2019
- Tweets156
- Following596
- Followers594
- Likes9.1K
Jordan T. Said, MD retweeted
After its success in pancreatic cancer, daraxonrasib’s NSCLC data!
In pretreated non-G12C RAS-mutant NSCLC, ORR was 35% overall; 42% in selected 2L cohort (mPFS 8.3 mo; mOS 16 mo).
Toxicity matters: at 160–220 mg, rash 90%, diarrhea 66%, G≥3 TRAEs 25%; at 300 mg, G≥3 TRAEs 45%. (Four G5 AE / non drug related)
nejm.org/doi/full/10.1056/NE…
Jordan T. Said, MD retweeted
New from our group in @JAMADerm: Skin eruptions after lifileucel/IL-2 for advanced melanoma are common (50%), self-limited, and prognostically favorable - ~7x higher odds of radiographic response at day 42.
@JordanTSaid @gmboland @bbuchbinderMD @dliu_ccb
tinyurl.com/yb5vw8bn
🤗 Thrilled to see this out in JAMA Derm - was fantastic to be part of this collaboration with the DFCI and MGB oncoderm and melanoma TIL teams! New therapies, new rashes! ♋️ 💉
In advanced #Melanoma, lifileucel-associated purpuric morbilliform eruptions were linked to higher 42-day radiographic response rates, suggesting prognostic value as a short-term efficacy marker. ja.ma/42aOhUN
Jordan T. Said, MD retweeted
The time of day for cancer immunotherapy is associated with major outcomes. Early is better. Results from a randomized trial of lung cancer, backs up the importance of our circadian rhythm and immune system
nature.com/articles/s41591-0…
Jordan T. Said, MD retweeted
This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.
Jordan T. Said, MD retweeted
From our Medicine and the Muse 🎶 event to Resident Research Day, we had a blast showcasing our residents’ diverse talents!
Jordan T. Said, MD retweeted
Big congratulations to all medical students matching today!
Especially excited to welcome the new 2025-2026 Class of @BrighamWomens Internal Medicine Interns!
We are looking forward to working with you all very soon!
@harvardmed @MassGenBrigham @BrighamMedRes @MGBResearchNews
Jordan T. Said, MD retweeted
We show that #CHIP is a novel risk factor for ICI myocarditis 🫀, similar to risk of dual ICI therapy. This has implications for evaluation of CHIP in those planned for ICI therapy & tailoring monitoring strategies. rdcu.be/d1BcT #CHIP #Immunotherapy @Yale
Jordan T. Said, MD retweeted
Happy to share our recent pub: Development and Validation of Algorithms to Identify Individuals With Cutaneous Lupus From Healthcare Databases; hopefully facilitates administrative claims database work in CLE @UTSWDerm journals.sagepub.com/doi/10.…
Jordan T. Said, MD retweeted
1 year after #BarbieMovie’s release, we asked whether the movie’s closing joke spurred public interest in gynecology in a study out today in @JAMANetworkOpen (led by Eva Sénéchal, w/ @Bray_Charles_ & @AnupamBJena)
🧵👇
🔓paper: jamanetwork.com/journals/jam…
@wbpictures @RPLuckyChap
Jordan T. Said, MD retweeted
Please join us in congratulating all of our 2024 Boston Marathon runners!! Amazing job everyone!!
🏃♀️🏃♂️🥇💪
Dr. Nicole LeBoeuf
Dr. Hillary Tsibris
Dr. Nicole Gunasekera
Jeremy Odena, LPN
& thank you to all of our BWH Dermatology Boston Marathon volunteers and supporters!!
The best Med-Derm family reunion at @MedDermSoc !!! 💙💙💙
@MedDermSoc @UTSWDerm @bwhdermatology #dermtwitter Reunited with my favorite people ❤️ 😢 @ the Med Derm Society meeting
Jordan T. Said, MD retweeted
Our Med Derm Family is forever!! #AAD2024 @beccagaff @JordanTSaid @lisanguo @SaraBehbahani1 – at San Diego, CA
@MedDermSoc @UTSWDerm @bwhdermatology #dermtwitter Reunited with my favorite people ❤️ 😢 @ the Med Derm Society meeting
We cannot WAIT to meet you all!!!!! 🏥 🫶💙
It’s that great time of year when we find out about the next generation of MDs joining us at @BrighamWomens!
Welcome to the incredible new @BrighamMedRes Intern Class of 2024!
Amazing to see that 21% from URIM backgrounds! @Brigham_DI
Jordan T. Said, MD retweeted
Nivo, pembro, atezo, durva, cemiplimab and avelumab discussing next steps
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Purple bumps, inpatient Derm, and Oncoderm galore! 💜
No better way to start off a week than with a great @BrighamMedRes Med-Derm morning report, especially with @AMostaghimi! (will have to remember my bow tie for next time…)
Phenomenal @BrighamMedRes morning report with the med derm dream team @JordanTSaid and @AMostaghimi exploring the “purple bump” differential in oncology patients! 🟣
Jordan T. Said, MD retweeted
This morning, I spoke at my alma mater to @BrighamWomens residents and faculty to talk all things medicine and public health. I wouldn’t be where I am today without the extraordinary mentors and colleagues at BWH—will always be grateful for them.
ALT U.S. Surgeon General Vivek Murthy in conversation.
ALT U.S. Surgeon General Vivek Murthy standing with a member of the Brigham and Women's Hospital community.
ALT U.S. Surgeon General Vivek Murthy taking a group photo with residents and faculty of Brigham and Women's Hospital.
ALT U.S. Surgeon General Vivek Murthy taking a group photo with residents and faculty of Brigham and Women's Hospital.
Jordan T. Said, MD retweeted
We are so excited to share an update about our program @HMSCombinedDerm!!
Starting now! #dermtwitter #meded #medtwitter
Jordan T. Said, MD retweeted
SAVE THE DATE! The Dermatology Application Season is Officially Here!!! Don’t miss HMS Derm Program’s Information Session and Resident Meet & Greet on September 12th at 7:00PM ET. Register here!! tinyurl.com/HMSDerm #match2024 #derm #medderm #HMSDerm – at Boston, MA
